Asters has advised the EBRD on a EUR 25 million loan to Yuria-Pharm, a Ukrainian manufacturer of intensive care medicines, medical devices, and antiseptics.
According to Asters, "A six-year loan of up to EUR 25 million from the EBRD will help Yuria-Pharm expand its existing production facilities and introduce an innovative solution for the Ukrainian market, which will help customize cancer treatment practices. Healthcare establishments and patients across Ukraine will be able to buy smaller and cheaper doses of specialized medicines."
Asters’ team consisted of Partner Iryna Pokanay, Counsel Gabriel Aslanian, and Associates Inna Bondarenko and Viktoria Zagreba.